Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
11.40%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth11.40%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-66.64%
40%
—
—
Never
—
5 Years
Score—
Net Growth-66.64%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Oncolytics Biotech Inc fundamental performance
Across Oncolytics Biotech Inc's full reported history, from 1999 to 2025, revenue declined from $ 1.00 to $ 0.00 and net income went from -$ 574.46K to -$ 39M. Revenue increased in 22% of the years measured; net income in 33%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.82 | — |
1 Year2025-08-12 | $ 0.86 | -4.25% |
5 Years2021-08-12 | $ 2.20 | -62.56% |
10 Years2016-08-12 | $ 3.04 | -72.90% |
20 Years2006-08-11 | $ 23.63 | -96.51% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 0.82 | $ 0.86 | $ 2.20 | $ 3.04 | $ 23.63 |
| Return | — | -4.25% | -62.56% | -72.90% | -96.51% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 34M | $ 7M |
| 2025 | $ 0.00 | -$ 39M | $ 7M |
| 2024 | $ 0.00 | -$ 31M | $ 15M |
| 2023 | $ 0.00 | -$ 20M | $ 34M |
| 2022 | $ 0.00 | -$ 19M | $ 32M |
| 2021 | $ 0.00 | -$ 20M | $ 41M |
| 2020 | $ 0.00 | -$ 16M | $ 31M |
| 2019 | $ 0.00 | -$ 45M | $ 14M |
| 2018 | $ 0.00 | -$ 17M | $ 13M |
| 2017 | $ 0.00 | -$ 15M | $ 11M |
| 2016 | $ 0.00 | -$ 15M | $ 14M |
| 2015 | $ 0.00 | -$ 13M | $ 26M |
| 2014 | $ 0.00 | -$ 18M | $ 16M |
| 2013 | $ 0.00 | -$ 23M | $ 27M |
| 2012 | $ 4M | -$ 36M | $ 21M |
| 2011 | $ 0.00 | -$ 29M | $ 34M |
| 2010 | $ 0.00 | -$ 19M | $ 42M |
| 2009 | $ 0.00 | -$ 16M | $ 35M |
| 2008 | $ 0.00 | -$ 17M | $ 13M |
| 2007 | $ 0.00 | -$ 15M | $ 25M |
| 2006 | $ 0.00 | -$ 14M | $ 27M |
| 2005 | $ 783.46K | -$ 12M | $ 40M |
| 2004 | $ 699.76K | -$ 12M | $ 33M |
| 2003 | $ 313.31K | -$ 8M | $ 20M |
| 2002 | $ 208.87K | -$ 6M | $ 8M |
| 2001 | $ 0.00 | -$ 6M | $ 14M |
| 2000 | $ 310K | -$ 3M | $ 17M |
| IPO1999 | $ 1.00 | -$ 574.46K | $ 4M |
Explore beyond ONCY
You're looking at Oncolytics Biotech Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
